KWALITY PHARMACEUTICALS
Back to Balance Sheet
|
KWALITY PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹152 Cr | ₹126 Cr | ₹139 Cr | ₹78 Cr | ₹68 Cr |
What is the latest Total Current Liabilities ratio of KWALITY PHARMACEUTICALS ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹152 Cr |
Mar2023 | ₹126 Cr |
Mar2022 | ₹139 Cr |
Mar2021 | ₹78 Cr |
Mar2020 | ₹68 Cr |
How is Total Current Liabilities of KWALITY PHARMACEUTICALS Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹152 Cr | 20.57 | |
Mar2023 | ₹126 Cr | -9.71 | |
Mar2022 | ₹139 Cr | 78.16 | |
Mar2021 | ₹78 Cr | 15.55 | |
Mar2020 | ₹68 Cr | - |
Compare Total Current Liabilities of peers of KWALITY PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KWALITY PHARMACEUTICALS | ₹739.3 Cr | -5.9% | -19.9% | 34.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,617.0 Cr | -2.1% | -9% | 9.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,655.0 Cr | 2.4% | 2.2% | 59.7% | Stock Analytics | |
CIPLA | ₹119,511.0 Cr | 1.4% | 2% | 0.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹104,734.0 Cr | -0.9% | -2.8% | 16.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,705.1 Cr | -2.1% | -9.2% | -8.7% | Stock Analytics |
KWALITY PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KWALITY PHARMACEUTICALS | -5.9% |
-19.9% |
34.9% |
SENSEX | -0.4% |
-1.4% |
5.4% |
You may also like the below Video Courses